ORAGENICS INC — Director's Dealing 2016

Jun 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN.BC)
CIK: 0001174940
Period of Report: 2016-06-06

Reporting Person: Joslyn Alan (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-06	Common Stock	A	30000	$0.00	Acquired	30000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-06	Employee Director Option (Right to Buy)	$0.55	A	300000	Acquired	2026-06-06	Common Stock (300000)	Direct

Footnotes

F1: Represents an award of restricted stock in connection with service to the Company as its Chief Executive Officer and director pursuant to the 2012 Equity Incentive Plan. One half of the shares vest in six months and the second half vest on the anniversary of the grant.

F2: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as its Chief Executive Officer and director. The options vest equally every six months over three years commencing six months from the grant date. The option exercise price is the closing price on the date immediately prior to the date of the grant, June 6, 2016.